nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—NISCH—Clonidine—glaucoma	0.126	0.146	CbGbCtD
Phentolamine—ADRA2C—Brimonidine—glaucoma	0.0695	0.0808	CbGbCtD
Phentolamine—ADRA2C—Apraclonidine—glaucoma	0.0695	0.0808	CbGbCtD
Phentolamine—ADRA2B—Brimonidine—glaucoma	0.0659	0.0766	CbGbCtD
Phentolamine—ADRA2B—Apraclonidine—glaucoma	0.0659	0.0766	CbGbCtD
Phentolamine—ADRA2C—Dipivefrin—glaucoma	0.0555	0.0646	CbGbCtD
Phentolamine—ADRA2B—Dipivefrin—glaucoma	0.0527	0.0612	CbGbCtD
Phentolamine—ADRA2A—Apraclonidine—glaucoma	0.0458	0.0533	CbGbCtD
Phentolamine—ADRA2A—Brimonidine—glaucoma	0.0458	0.0533	CbGbCtD
Phentolamine—ADRA1A—Apraclonidine—glaucoma	0.0439	0.0511	CbGbCtD
Phentolamine—ADRA2A—Dipivefrin—glaucoma	0.0366	0.0426	CbGbCtD
Phentolamine—ADRA1A—Dipivefrin—glaucoma	0.0351	0.0408	CbGbCtD
Phentolamine—ADRA1D—Clonidine—glaucoma	0.0318	0.0369	CbGbCtD
Phentolamine—ADRA2C—Clonidine—glaucoma	0.0288	0.0335	CbGbCtD
Phentolamine—ADRA2B—Clonidine—glaucoma	0.0274	0.0318	CbGbCtD
Phentolamine—ADRA1B—Clonidine—glaucoma	0.0231	0.0269	CbGbCtD
Phentolamine—ADRA2A—Clonidine—glaucoma	0.019	0.0221	CbGbCtD
Phentolamine—ADRA1A—Clonidine—glaucoma	0.0182	0.0212	CbGbCtD
Phentolamine—Angiopathy—Apraclonidine—glaucoma	0.000634	0.00457	CcSEcCtD
Phentolamine—Mediastinal disorder—Apraclonidine—glaucoma	0.00063	0.00454	CcSEcCtD
Phentolamine—Acute coronary syndrome—Dorzolamide—glaucoma	0.00063	0.00453	CcSEcCtD
Phentolamine—Hypotension—Levobunolol—glaucoma	0.000626	0.00451	CcSEcCtD
Phentolamine—Paraesthesia—Diclofenamide—glaucoma	0.000626	0.00451	CcSEcCtD
Phentolamine—Myocardial infarction—Dorzolamide—glaucoma	0.000626	0.00451	CcSEcCtD
Phentolamine—Arrhythmia—Apraclonidine—glaucoma	0.000625	0.0045	CcSEcCtD
Phentolamine—Angiopathy—Bimatoprost—glaucoma	0.000615	0.00443	CcSEcCtD
Phentolamine—Blood pressure increased—Timolol—glaucoma	0.000613	0.00441	CcSEcCtD
Phentolamine—Bradycardia—Brimonidine—glaucoma	0.000611	0.0044	CcSEcCtD
Phentolamine—Mediastinal disorder—Bimatoprost—glaucoma	0.000611	0.0044	CcSEcCtD
Phentolamine—Nervous system disorder—Latanoprost—glaucoma	0.000609	0.00439	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Diclofenamide—glaucoma	0.000602	0.00433	CcSEcCtD
Phentolamine—Paraesthesia—Levobunolol—glaucoma	0.000602	0.00433	CcSEcCtD
Phentolamine—Acute coronary syndrome—Pilocarpine—glaucoma	0.000595	0.00428	CcSEcCtD
Phentolamine—Myocardial infarction—Pilocarpine—glaucoma	0.000592	0.00426	CcSEcCtD
Phentolamine—Bradycardia—Dorzolamide—glaucoma	0.000584	0.0042	CcSEcCtD
Phentolamine—Pain—Carbachol—glaucoma	0.000582	0.00419	CcSEcCtD
Phentolamine—Bradycardia—Travoprost—glaucoma	0.000581	0.00418	CcSEcCtD
Phentolamine—Flushing—Acetazolamide—glaucoma	0.000581	0.00418	CcSEcCtD
Phentolamine—Paraesthesia—Methazolamide—glaucoma	0.000576	0.00415	CcSEcCtD
Phentolamine—Bradycardia—Brinzolamide—glaucoma	0.000574	0.00413	CcSEcCtD
Phentolamine—Pain—Levobunolol—glaucoma	0.000573	0.00412	CcSEcCtD
Phentolamine—Orthostatic hypotension—Clonidine—glaucoma	0.000571	0.00411	CcSEcCtD
Phentolamine—Abdominal pain upper—Clonidine—glaucoma	0.000571	0.00411	CcSEcCtD
Phentolamine—Flushing—Brimonidine—glaucoma	0.000557	0.00401	CcSEcCtD
Phentolamine—Cardiac disorder—Brimonidine—glaucoma	0.000557	0.00401	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methazolamide—glaucoma	0.000554	0.00399	CcSEcCtD
Phentolamine—Bradycardia—Pilocarpine—glaucoma	0.000552	0.00397	CcSEcCtD
Phentolamine—Asthenia—Metipranolol—glaucoma	0.000549	0.00395	CcSEcCtD
Phentolamine—Angiopathy—Brimonidine—glaucoma	0.000545	0.00392	CcSEcCtD
Phentolamine—Mediastinal disorder—Brimonidine—glaucoma	0.000541	0.00389	CcSEcCtD
Phentolamine—Abdominal pain—Carbachol—glaucoma	0.000538	0.00387	CcSEcCtD
Phentolamine—Arrhythmia—Brimonidine—glaucoma	0.000536	0.00386	CcSEcCtD
Phentolamine—Pain—Latanoprost—glaucoma	0.000531	0.00382	CcSEcCtD
Phentolamine—Cardiac disorder—Travoprost—glaucoma	0.00053	0.00381	CcSEcCtD
Phentolamine—Cardiac disorder—Brinzolamide—glaucoma	0.000523	0.00377	CcSEcCtD
Phentolamine—Chest pain—Apraclonidine—glaucoma	0.000518	0.00373	CcSEcCtD
Phentolamine—Angiopathy—Travoprost—glaucoma	0.000518	0.00373	CcSEcCtD
Phentolamine—Mediastinal disorder—Travoprost—glaucoma	0.000514	0.0037	CcSEcCtD
Phentolamine—Arrhythmia—Dorzolamide—glaucoma	0.000512	0.00369	CcSEcCtD
Phentolamine—Angiopathy—Brinzolamide—glaucoma	0.000511	0.00368	CcSEcCtD
Phentolamine—Hypertension—Bimatoprost—glaucoma	0.00051	0.00367	CcSEcCtD
Phentolamine—Asthenia—Carteolol—glaucoma	0.000509	0.00366	CcSEcCtD
Phentolamine—Mediastinal disorder—Brinzolamide—glaucoma	0.000508	0.00366	CcSEcCtD
Phentolamine—Dizziness—Metipranolol—glaucoma	0.000506	0.00364	CcSEcCtD
Phentolamine—Arrhythmia—Brinzolamide—glaucoma	0.000504	0.00362	CcSEcCtD
Phentolamine—Flushing—Pilocarpine—glaucoma	0.000503	0.00362	CcSEcCtD
Phentolamine—Chest pain—Bimatoprost—glaucoma	0.000502	0.00362	CcSEcCtD
Phentolamine—Asthenia—Diclofenamide—glaucoma	0.0005	0.0036	CcSEcCtD
Phentolamine—Pruritus—Diclofenamide—glaucoma	0.000493	0.00355	CcSEcCtD
Phentolamine—Nasal congestion—Timolol—glaucoma	0.000488	0.00351	CcSEcCtD
Phentolamine—Nervous system disorder—Apraclonidine—glaucoma	0.000487	0.00351	CcSEcCtD
Phentolamine—Arrhythmia—Pilocarpine—glaucoma	0.000484	0.00348	CcSEcCtD
Phentolamine—Asthenia—Levobunolol—glaucoma	0.000481	0.00346	CcSEcCtD
Phentolamine—Headache—Metipranolol—glaucoma	0.00048	0.00345	CcSEcCtD
Phentolamine—Pruritus—Levobunolol—glaucoma	0.000474	0.00341	CcSEcCtD
Phentolamine—Nervous system disorder—Bimatoprost—glaucoma	0.000472	0.0034	CcSEcCtD
Phentolamine—Dizziness—Carteolol—glaucoma	0.000469	0.00338	CcSEcCtD
Phentolamine—Diarrhoea—Carbachol—glaucoma	0.000466	0.00335	CcSEcCtD
Phentolamine—Dizziness—Diclofenamide—glaucoma	0.000461	0.00332	CcSEcCtD
Phentolamine—Asthenia—Methazolamide—glaucoma	0.000461	0.00332	CcSEcCtD
Phentolamine—Diarrhoea—Levobunolol—glaucoma	0.000459	0.0033	CcSEcCtD
Phentolamine—Angina pectoris—Betaxolol—glaucoma	0.000458	0.0033	CcSEcCtD
Phentolamine—Nausea—Metipranolol—glaucoma	0.000455	0.00327	CcSEcCtD
Phentolamine—Hypertension—Brimonidine—glaucoma	0.000451	0.00325	CcSEcCtD
Phentolamine—Dizziness—Carbachol—glaucoma	0.00045	0.00324	CcSEcCtD
Phentolamine—Paraesthesia—Apraclonidine—glaucoma	0.000446	0.00321	CcSEcCtD
Phentolamine—Chest pain—Brimonidine—glaucoma	0.000445	0.0032	CcSEcCtD
Phentolamine—Headache—Carteolol—glaucoma	0.000444	0.0032	CcSEcCtD
Phentolamine—Vomiting—Diclofenamide—glaucoma	0.000443	0.00319	CcSEcCtD
Phentolamine—Dizziness—Levobunolol—glaucoma	0.000443	0.00319	CcSEcCtD
Phentolamine—Bradycardia—Clonidine—glaucoma	0.00044	0.00317	CcSEcCtD
Phentolamine—Pruritus—Latanoprost—glaucoma	0.00044	0.00316	CcSEcCtD
Phentolamine—Diarrhoea—Methazolamide—glaucoma	0.000439	0.00316	CcSEcCtD
Phentolamine—Headache—Diclofenamide—glaucoma	0.000437	0.00314	CcSEcCtD
Phentolamine—Vomiting—Carbachol—glaucoma	0.000433	0.00311	CcSEcCtD
Phentolamine—Hypertension—Dorzolamide—glaucoma	0.000431	0.0031	CcSEcCtD
Phentolamine—Hypertension—Travoprost—glaucoma	0.000429	0.00309	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000429	0.00309	CcSEcCtD
Phentolamine—Headache—Carbachol—glaucoma	0.000426	0.00307	CcSEcCtD
Phentolamine—Chest pain—Dorzolamide—glaucoma	0.000425	0.00306	CcSEcCtD
Phentolamine—Pain—Apraclonidine—glaucoma	0.000425	0.00306	CcSEcCtD
Phentolamine—Hypertension—Brinzolamide—glaucoma	0.000424	0.00305	CcSEcCtD
Phentolamine—Chest pain—Travoprost—glaucoma	0.000423	0.00305	CcSEcCtD
Phentolamine—Nausea—Carteolol—glaucoma	0.000421	0.00303	CcSEcCtD
Phentolamine—Headache—Levobunolol—glaucoma	0.00042	0.00302	CcSEcCtD
Phentolamine—Nervous system disorder—Brimonidine—glaucoma	0.000418	0.00301	CcSEcCtD
Phentolamine—Chest pain—Brinzolamide—glaucoma	0.000418	0.00301	CcSEcCtD
Phentolamine—Tachycardia—Brimonidine—glaucoma	0.000416	0.003	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000416	0.00299	CcSEcCtD
Phentolamine—Nausea—Diclofenamide—glaucoma	0.000414	0.00298	CcSEcCtD
Phentolamine—Acute coronary syndrome—Betaxolol—glaucoma	0.000414	0.00298	CcSEcCtD
Phentolamine—Pain—Bimatoprost—glaucoma	0.000412	0.00296	CcSEcCtD
Phentolamine—Myocardial infarction—Betaxolol—glaucoma	0.000411	0.00296	CcSEcCtD
Phentolamine—Dizziness—Latanoprost—glaucoma	0.000411	0.00296	CcSEcCtD
Phentolamine—Vomiting—Methazolamide—glaucoma	0.000408	0.00294	CcSEcCtD
Phentolamine—Hypertension—Pilocarpine—glaucoma	0.000407	0.00293	CcSEcCtD
Phentolamine—Gastrointestinal pain—Apraclonidine—glaucoma	0.000406	0.00292	CcSEcCtD
Phentolamine—Abdominal pain upper—Timolol—glaucoma	0.000406	0.00292	CcSEcCtD
Phentolamine—Nausea—Carbachol—glaucoma	0.000404	0.00291	CcSEcCtD
Phentolamine—Headache—Methazolamide—glaucoma	0.000402	0.00289	CcSEcCtD
Phentolamine—Cardiac disorder—Clonidine—glaucoma	0.000402	0.00289	CcSEcCtD
Phentolamine—Chest pain—Pilocarpine—glaucoma	0.000401	0.00289	CcSEcCtD
Phentolamine—Paraesthesia—Acetazolamide—glaucoma	0.000399	0.00287	CcSEcCtD
Phentolamine—Hypotension—Brimonidine—glaucoma	0.000399	0.00287	CcSEcCtD
Phentolamine—Nausea—Levobunolol—glaucoma	0.000398	0.00286	CcSEcCtD
Phentolamine—Nervous system disorder—Travoprost—glaucoma	0.000398	0.00286	CcSEcCtD
Phentolamine—Tachycardia—Travoprost—glaucoma	0.000396	0.00285	CcSEcCtD
Phentolamine—Abdominal pain—Apraclonidine—glaucoma	0.000393	0.00283	CcSEcCtD
Phentolamine—Nervous system disorder—Brinzolamide—glaucoma	0.000393	0.00283	CcSEcCtD
Phentolamine—Angiopathy—Clonidine—glaucoma	0.000393	0.00283	CcSEcCtD
Phentolamine—Tachycardia—Brinzolamide—glaucoma	0.000391	0.00281	CcSEcCtD
Phentolamine—Mediastinal disorder—Clonidine—glaucoma	0.00039	0.00281	CcSEcCtD
Phentolamine—Headache—Latanoprost—glaucoma	0.000389	0.0028	CcSEcCtD
Phentolamine—Arrhythmia—Clonidine—glaucoma	0.000386	0.00278	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000384	0.00276	CcSEcCtD
Phentolamine—Bradycardia—Betaxolol—glaucoma	0.000383	0.00276	CcSEcCtD
Phentolamine—Paraesthesia—Brimonidine—glaucoma	0.000383	0.00276	CcSEcCtD
Phentolamine—Nausea—Methazolamide—glaucoma	0.000381	0.00274	CcSEcCtD
Phentolamine—Hypotension—Dorzolamide—glaucoma	0.000381	0.00274	CcSEcCtD
Phentolamine—Hypotension—Travoprost—glaucoma	0.000379	0.00273	CcSEcCtD
Phentolamine—Tachycardia—Pilocarpine—glaucoma	0.000376	0.0027	CcSEcCtD
Phentolamine—Angina pectoris—Timolol—glaucoma	0.000374	0.0027	CcSEcCtD
Phentolamine—Hypotension—Brinzolamide—glaucoma	0.000374	0.00269	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000368	0.00265	CcSEcCtD
Phentolamine—Paraesthesia—Dorzolamide—glaucoma	0.000366	0.00263	CcSEcCtD
Phentolamine—Pain—Brimonidine—glaucoma	0.000365	0.00263	CcSEcCtD
Phentolamine—Hypotension—Pilocarpine—glaucoma	0.00036	0.00259	CcSEcCtD
Phentolamine—Paraesthesia—Brinzolamide—glaucoma	0.00036	0.00259	CcSEcCtD
Phentolamine—Asthenia—Apraclonidine—glaucoma	0.000356	0.00257	CcSEcCtD
Phentolamine—Pruritus—Apraclonidine—glaucoma	0.000351	0.00253	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Travoprost—glaucoma	0.00035	0.00252	CcSEcCtD
Phentolamine—Flushing—Betaxolol—glaucoma	0.00035	0.00252	CcSEcCtD
Phentolamine—Cardiac disorder—Betaxolol—glaucoma	0.00035	0.00252	CcSEcCtD
Phentolamine—Pain—Dorzolamide—glaucoma	0.000348	0.00251	CcSEcCtD
Phentolamine—Pain—Travoprost—glaucoma	0.000347	0.0025	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000346	0.00249	CcSEcCtD
Phentolamine—Paraesthesia—Pilocarpine—glaucoma	0.000346	0.00249	CcSEcCtD
Phentolamine—Asthenia—Bimatoprost—glaucoma	0.000346	0.00249	CcSEcCtD
Phentolamine—Pain—Brinzolamide—glaucoma	0.000342	0.00246	CcSEcCtD
Phentolamine—Angiopathy—Betaxolol—glaucoma	0.000342	0.00246	CcSEcCtD
Phentolamine—Pruritus—Bimatoprost—glaucoma	0.000341	0.00245	CcSEcCtD
Phentolamine—Diarrhoea—Apraclonidine—glaucoma	0.00034	0.00245	CcSEcCtD
Phentolamine—Mediastinal disorder—Betaxolol—glaucoma	0.000339	0.00244	CcSEcCtD
Phentolamine—Arrhythmia—Betaxolol—glaucoma	0.000336	0.00242	CcSEcCtD
Phentolamine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000333	0.0024	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000332	0.00239	CcSEcCtD
Phentolamine—Gastrointestinal pain—Travoprost—glaucoma	0.000332	0.00239	CcSEcCtD
Phentolamine—Pain—Pilocarpine—glaucoma	0.000329	0.00237	CcSEcCtD
Phentolamine—Dizziness—Apraclonidine—glaucoma	0.000329	0.00236	CcSEcCtD
Phentolamine—Abdominal pain—Dorzolamide—glaucoma	0.000322	0.00232	CcSEcCtD
Phentolamine—Chest pain—Clonidine—glaucoma	0.000321	0.00231	CcSEcCtD
Phentolamine—Abdominal pain—Travoprost—glaucoma	0.000321	0.00231	CcSEcCtD
Phentolamine—Asthenia—Acetazolamide—glaucoma	0.000319	0.00229	CcSEcCtD
Phentolamine—Dizziness—Bimatoprost—glaucoma	0.000319	0.00229	CcSEcCtD
Phentolamine—Vomiting—Apraclonidine—glaucoma	0.000316	0.00227	CcSEcCtD
Phentolamine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000315	0.00227	CcSEcCtD
Phentolamine—Bradycardia—Timolol—glaucoma	0.000313	0.00225	CcSEcCtD
Phentolamine—Headache—Apraclonidine—glaucoma	0.000311	0.00224	CcSEcCtD
Phentolamine—Asthenia—Brimonidine—glaucoma	0.000306	0.0022	CcSEcCtD
Phentolamine—Abdominal pain—Pilocarpine—glaucoma	0.000304	0.00219	CcSEcCtD
Phentolamine—Diarrhoea—Acetazolamide—glaucoma	0.000304	0.00219	CcSEcCtD
Phentolamine—Pruritus—Brimonidine—glaucoma	0.000302	0.00217	CcSEcCtD
Phentolamine—Headache—Bimatoprost—glaucoma	0.000302	0.00217	CcSEcCtD
Phentolamine—Nervous system disorder—Clonidine—glaucoma	0.000301	0.00217	CcSEcCtD
Phentolamine—Tachycardia—Clonidine—glaucoma	0.0003	0.00216	CcSEcCtD
Phentolamine—Nausea—Apraclonidine—glaucoma	0.000295	0.00212	CcSEcCtD
Phentolamine—Dizziness—Acetazolamide—glaucoma	0.000294	0.00212	CcSEcCtD
Phentolamine—Asthenia—Dorzolamide—glaucoma	0.000292	0.0021	CcSEcCtD
Phentolamine—Asthenia—Travoprost—glaucoma	0.000291	0.00209	CcSEcCtD
Phentolamine—Pruritus—Dorzolamide—glaucoma	0.000288	0.00207	CcSEcCtD
Phentolamine—Asthenia—Brinzolamide—glaucoma	0.000287	0.00207	CcSEcCtD
Phentolamine—Hypotension—Clonidine—glaucoma	0.000287	0.00207	CcSEcCtD
Phentolamine—Pruritus—Travoprost—glaucoma	0.000287	0.00207	CcSEcCtD
Phentolamine—Nausea—Bimatoprost—glaucoma	0.000286	0.00206	CcSEcCtD
Phentolamine—Cardiac disorder—Timolol—glaucoma	0.000286	0.00206	CcSEcCtD
Phentolamine—Pruritus—Brinzolamide—glaucoma	0.000283	0.00204	CcSEcCtD
Phentolamine—Vomiting—Acetazolamide—glaucoma	0.000283	0.00203	CcSEcCtD
Phentolamine—Dizziness—Brimonidine—glaucoma	0.000282	0.00203	CcSEcCtD
Phentolamine—Angiopathy—Timolol—glaucoma	0.000279	0.00201	CcSEcCtD
Phentolamine—Chest pain—Betaxolol—glaucoma	0.000279	0.00201	CcSEcCtD
Phentolamine—Diarrhoea—Dorzolamide—glaucoma	0.000279	0.00201	CcSEcCtD
Phentolamine—Headache—Acetazolamide—glaucoma	0.000278	0.002	CcSEcCtD
Phentolamine—Diarrhoea—Travoprost—glaucoma	0.000277	0.002	CcSEcCtD
Phentolamine—Mediastinal disorder—Timolol—glaucoma	0.000277	0.002	CcSEcCtD
Phentolamine—Asthenia—Pilocarpine—glaucoma	0.000276	0.00199	CcSEcCtD
Phentolamine—Paraesthesia—Clonidine—glaucoma	0.000276	0.00199	CcSEcCtD
Phentolamine—Arrhythmia—Timolol—glaucoma	0.000275	0.00198	CcSEcCtD
Phentolamine—Diarrhoea—Brinzolamide—glaucoma	0.000274	0.00197	CcSEcCtD
Phentolamine—Pruritus—Pilocarpine—glaucoma	0.000272	0.00196	CcSEcCtD
Phentolamine—Dizziness—Dorzolamide—glaucoma	0.000269	0.00194	CcSEcCtD
Phentolamine—Dizziness—Travoprost—glaucoma	0.000268	0.00193	CcSEcCtD
Phentolamine—Headache—Brimonidine—glaucoma	0.000267	0.00192	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Clonidine—glaucoma	0.000265	0.00191	CcSEcCtD
Phentolamine—Dizziness—Brinzolamide—glaucoma	0.000265	0.00191	CcSEcCtD
Phentolamine—Nausea—Acetazolamide—glaucoma	0.000264	0.0019	CcSEcCtD
Phentolamine—Diarrhoea—Pilocarpine—glaucoma	0.000263	0.0019	CcSEcCtD
Phentolamine—Pain—Clonidine—glaucoma	0.000263	0.00189	CcSEcCtD
Phentolamine—Nervous system disorder—Betaxolol—glaucoma	0.000262	0.00189	CcSEcCtD
Phentolamine—Tachycardia—Betaxolol—glaucoma	0.000261	0.00188	CcSEcCtD
Phentolamine—Vomiting—Dorzolamide—glaucoma	0.000259	0.00186	CcSEcCtD
Phentolamine—Headache—Dorzolamide—glaucoma	0.000255	0.00184	CcSEcCtD
Phentolamine—Vomiting—Brinzolamide—glaucoma	0.000255	0.00183	CcSEcCtD
Phentolamine—Dizziness—Pilocarpine—glaucoma	0.000255	0.00183	CcSEcCtD
Phentolamine—Headache—Travoprost—glaucoma	0.000254	0.00183	CcSEcCtD
Phentolamine—Nausea—Brimonidine—glaucoma	0.000253	0.00182	CcSEcCtD
Phentolamine—Gastrointestinal pain—Clonidine—glaucoma	0.000251	0.00181	CcSEcCtD
Phentolamine—Headache—Brinzolamide—glaucoma	0.000251	0.00181	CcSEcCtD
Phentolamine—Hypotension—Betaxolol—glaucoma	0.00025	0.0018	CcSEcCtD
Phentolamine—Vomiting—Pilocarpine—glaucoma	0.000245	0.00176	CcSEcCtD
Phentolamine—Abdominal pain—Clonidine—glaucoma	0.000243	0.00175	CcSEcCtD
Phentolamine—Nausea—Dorzolamide—glaucoma	0.000242	0.00174	CcSEcCtD
Phentolamine—Headache—Pilocarpine—glaucoma	0.000241	0.00174	CcSEcCtD
Phentolamine—Nausea—Travoprost—glaucoma	0.000241	0.00173	CcSEcCtD
Phentolamine—Paraesthesia—Betaxolol—glaucoma	0.00024	0.00173	CcSEcCtD
Phentolamine—Nausea—Brinzolamide—glaucoma	0.000238	0.00171	CcSEcCtD
Phentolamine—Hypertension—Timolol—glaucoma	0.000231	0.00166	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000231	0.00166	CcSEcCtD
Phentolamine—Pain—Betaxolol—glaucoma	0.000229	0.00165	CcSEcCtD
Phentolamine—Nausea—Pilocarpine—glaucoma	0.000229	0.00165	CcSEcCtD
Phentolamine—Chest pain—Timolol—glaucoma	0.000228	0.00164	CcSEcCtD
Phentolamine—Asthenia—Clonidine—glaucoma	0.000221	0.00159	CcSEcCtD
Phentolamine—Pruritus—Clonidine—glaucoma	0.000217	0.00157	CcSEcCtD
Phentolamine—Nervous system disorder—Timolol—glaucoma	0.000214	0.00154	CcSEcCtD
Phentolamine—Diarrhoea—Clonidine—glaucoma	0.00021	0.00151	CcSEcCtD
Phentolamine—Hypotension—Timolol—glaucoma	0.000204	0.00147	CcSEcCtD
Phentolamine—Dizziness—Clonidine—glaucoma	0.000203	0.00146	CcSEcCtD
Phentolamine—Paraesthesia—Timolol—glaucoma	0.000196	0.00141	CcSEcCtD
Phentolamine—Vomiting—Clonidine—glaucoma	0.000195	0.00141	CcSEcCtD
Phentolamine—Headache—Clonidine—glaucoma	0.000193	0.00139	CcSEcCtD
Phentolamine—Asthenia—Betaxolol—glaucoma	0.000192	0.00138	CcSEcCtD
Phentolamine—Pruritus—Betaxolol—glaucoma	0.000189	0.00136	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Timolol—glaucoma	0.000189	0.00136	CcSEcCtD
Phentolamine—Pain—Timolol—glaucoma	0.000187	0.00135	CcSEcCtD
Phentolamine—Diarrhoea—Betaxolol—glaucoma	0.000183	0.00132	CcSEcCtD
Phentolamine—Nausea—Clonidine—glaucoma	0.000183	0.00131	CcSEcCtD
Phentolamine—Gastrointestinal pain—Timolol—glaucoma	0.000179	0.00129	CcSEcCtD
Phentolamine—Dizziness—Betaxolol—glaucoma	0.000177	0.00127	CcSEcCtD
Phentolamine—Abdominal pain—Timolol—glaucoma	0.000173	0.00124	CcSEcCtD
Phentolamine—Vomiting—Betaxolol—glaucoma	0.00017	0.00122	CcSEcCtD
Phentolamine—Headache—Betaxolol—glaucoma	0.000168	0.00121	CcSEcCtD
Phentolamine—Nausea—Betaxolol—glaucoma	0.000159	0.00114	CcSEcCtD
Phentolamine—Asthenia—Timolol—glaucoma	0.000157	0.00113	CcSEcCtD
Phentolamine—Pruritus—Timolol—glaucoma	0.000155	0.00111	CcSEcCtD
Phentolamine—Diarrhoea—Timolol—glaucoma	0.00015	0.00108	CcSEcCtD
Phentolamine—Dizziness—Timolol—glaucoma	0.000145	0.00104	CcSEcCtD
Phentolamine—Vomiting—Timolol—glaucoma	0.000139	0.001	CcSEcCtD
Phentolamine—Headache—Timolol—glaucoma	0.000137	0.000986	CcSEcCtD
Phentolamine—Nausea—Timolol—glaucoma	0.00013	0.000935	CcSEcCtD
Phentolamine—ADRA2C—Platelet activation, signaling and aggregation—FN1—glaucoma	2.38e-06	0.00234	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—SMO—glaucoma	2.37e-06	0.00233	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.35e-06	0.00231	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TGFB2—glaucoma	2.32e-06	0.00229	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.31e-06	0.00227	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—LRP12—glaucoma	2.28e-06	0.00225	CbGpPWpGaD
Phentolamine—ADRA1A—AMPK Signaling—TP53—glaucoma	2.28e-06	0.00225	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	2.24e-06	0.00221	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—SMO—glaucoma	2.2e-06	0.00217	CbGpPWpGaD
Phentolamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.2e-06	0.00216	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—OPN4—glaucoma	2.15e-06	0.00211	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—LRP12—glaucoma	2.12e-06	0.00209	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—EDN1—glaucoma	2.12e-06	0.00209	CbGpPWpGaD
Phentolamine—ADRA2A—G alpha (i) signalling events—C3—glaucoma	2.1e-06	0.00206	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.05e-06	0.00202	CbGpPWpGaD
Phentolamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.05e-06	0.00202	CbGpPWpGaD
Phentolamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.02e-06	0.00199	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CA1—glaucoma	2.01e-06	0.00198	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HEYL—glaucoma	2e-06	0.00196	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CTSA—glaucoma	1.95e-06	0.00192	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—OPN4—glaucoma	1.94e-06	0.00191	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—PTGFR—glaucoma	1.93e-06	0.0019	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	1.93e-06	0.0019	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—EDN1—glaucoma	1.91e-06	0.00188	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.91e-06	0.00188	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TGFB2—glaucoma	1.89e-06	0.00186	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—SOD1—glaucoma	1.89e-06	0.00186	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR ligand binding—C3—glaucoma	1.85e-06	0.00182	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CA2—glaucoma	1.84e-06	0.00181	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—OPN4—glaucoma	1.81e-06	0.00178	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HEYL—glaucoma	1.8e-06	0.00177	CbGpPWpGaD
Phentolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.79e-06	0.00176	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—EDN1—glaucoma	1.79e-06	0.00176	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—OPN4—glaucoma	1.78e-06	0.00175	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—SOD1—glaucoma	1.76e-06	0.00173	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—EDN1—glaucoma	1.76e-06	0.00173	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—PTGFR—glaucoma	1.75e-06	0.00172	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HEYL—glaucoma	1.68e-06	0.00166	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR ligand binding—C3—glaucoma	1.67e-06	0.00164	CbGpPWpGaD
Phentolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.67e-06	0.00164	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HEYL—glaucoma	1.66e-06	0.00163	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—SMO—glaucoma	1.65e-06	0.00162	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CA1—glaucoma	1.64e-06	0.00161	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—PTGFR—glaucoma	1.63e-06	0.0016	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—PTGFR—glaucoma	1.6e-06	0.00158	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CTSA—glaucoma	1.58e-06	0.00156	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—OPN4—glaucoma	1.58e-06	0.00156	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—EDN1—glaucoma	1.56e-06	0.00154	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR ligand binding—C3—glaucoma	1.56e-06	0.00154	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR ligand binding—C3—glaucoma	1.54e-06	0.00151	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—RPTOR—glaucoma	1.51e-06	0.00149	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CA2—glaucoma	1.5e-06	0.00147	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—SMO—glaucoma	1.49e-06	0.00147	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HEYL—glaucoma	1.47e-06	0.00145	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—OPN4—glaucoma	1.47e-06	0.00145	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NCK2—glaucoma	1.47e-06	0.00144	CbGpPWpGaD
Phentolamine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.46e-06	0.00143	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—EDN1—glaucoma	1.45e-06	0.00143	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—MMP1—glaucoma	1.44e-06	0.00142	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—SOD1—glaucoma	1.43e-06	0.00141	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—PTGFR—glaucoma	1.43e-06	0.0014	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—SMO—glaucoma	1.39e-06	0.00137	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—CAV1—glaucoma	1.38e-06	0.00136	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—SMO—glaucoma	1.37e-06	0.00135	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HEYL—glaucoma	1.37e-06	0.00135	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—RPTOR—glaucoma	1.37e-06	0.00134	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR ligand binding—C3—glaucoma	1.37e-06	0.00134	CbGpPWpGaD
Phentolamine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.36e-06	0.00134	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—MMP1—glaucoma	1.34e-06	0.00132	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—PTGFR—glaucoma	1.32e-06	0.0013	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NCK2—glaucoma	1.32e-06	0.0013	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—FN1—glaucoma	1.31e-06	0.00129	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—TXN—glaucoma	1.3e-06	0.00128	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—CAV1—glaucoma	1.29e-06	0.00127	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—RPTOR—glaucoma	1.28e-06	0.00126	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR ligand binding—C3—glaucoma	1.27e-06	0.00125	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—RPTOR—glaucoma	1.26e-06	0.00124	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—HDAC9—glaucoma	1.25e-06	0.00123	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NCK2—glaucoma	1.24e-06	0.00122	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—FN1—glaucoma	1.23e-06	0.00121	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—SMO—glaucoma	1.22e-06	0.0012	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NCK2—glaucoma	1.22e-06	0.0012	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—EDN1—glaucoma	1.2e-06	0.00118	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—SMO—glaucoma	1.13e-06	0.00111	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—HDAC9—glaucoma	1.12e-06	0.00111	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—RPTOR—glaucoma	1.12e-06	0.0011	CbGpPWpGaD
Phentolamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.11e-06	0.00109	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—MMP1—glaucoma	1.09e-06	0.00107	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—EDN1—glaucoma	1.09e-06	0.00107	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—EDN1—glaucoma	1.08e-06	0.00106	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NCK2—glaucoma	1.08e-06	0.00106	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—TXN—glaucoma	1.05e-06	0.00104	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—HDAC9—glaucoma	1.05e-06	0.00103	CbGpPWpGaD
Phentolamine—ADRA1D—GPCR downstream signaling—C3—glaucoma	1.05e-06	0.00103	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—CAV1—glaucoma	1.05e-06	0.00103	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—NOS3—glaucoma	1.04e-06	0.00103	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—RPTOR—glaucoma	1.04e-06	0.00102	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—HDAC9—glaucoma	1.03e-06	0.00102	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—EDN1—glaucoma	1.01e-06	0.000994	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTT1—glaucoma	1.01e-06	0.00099	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NCK2—glaucoma	1e-06	0.000987	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—FN1—glaucoma	9.96e-07	0.00098	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	9.94e-07	0.000978	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—EDN1—glaucoma	9.82e-07	0.000966	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—SMO—glaucoma	9.75e-07	0.000959	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—NOS3—glaucoma	9.74e-07	0.000958	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling by GPCR—C3—glaucoma	9.5e-07	0.000935	CbGpPWpGaD
Phentolamine—ADRA2B—GPCR downstream signaling—C3—glaucoma	9.45e-07	0.00093	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—HDAC9—glaucoma	9.18e-07	0.000904	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—EDN1—glaucoma	9.17e-07	0.000903	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—EDN1—glaucoma	9.03e-07	0.000888	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NTRK2—glaucoma	8.92e-07	0.000877	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	8.83e-07	0.000869	CbGpPWpGaD
Phentolamine—ADRA2C—GPCR downstream signaling—C3—glaucoma	8.83e-07	0.000868	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—SMO—glaucoma	8.8e-07	0.000866	CbGpPWpGaD
Phentolamine—ADRA1B—GPCR downstream signaling—C3—glaucoma	8.69e-07	0.000855	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling by GPCR—C3—glaucoma	8.58e-07	0.000844	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—HDAC9—glaucoma	8.53e-07	0.000839	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—SMO—glaucoma	8.22e-07	0.000809	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	8.21e-07	0.000807	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTT1—glaucoma	8.17e-07	0.000804	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—SMO—glaucoma	8.09e-07	0.000796	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NTRK2—glaucoma	8.05e-07	0.000792	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—EDN1—glaucoma	8.02e-07	0.000789	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling by GPCR—C3—glaucoma	8.01e-07	0.000789	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—ABCA1—glaucoma	8.01e-07	0.000788	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CYP1B1—glaucoma	8.01e-07	0.000788	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—NOS3—glaucoma	7.91e-07	0.000778	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling by GPCR—C3—glaucoma	7.89e-07	0.000776	CbGpPWpGaD
Phentolamine—ADRA1A—GPCR downstream signaling—C3—glaucoma	7.72e-07	0.000759	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NGFR—glaucoma	7.65e-07	0.000753	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NTRK2—glaucoma	7.52e-07	0.00074	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—VEGFA—glaucoma	7.51e-07	0.000739	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—EDN1—glaucoma	7.45e-07	0.000733	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NTRK2—glaucoma	7.4e-07	0.000728	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NTRK1—glaucoma	7.27e-07	0.000715	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—SMO—glaucoma	7.19e-07	0.000707	CbGpPWpGaD
Phentolamine—ADRA2A—GPCR downstream signaling—C3—glaucoma	7.17e-07	0.000705	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—VEGFA—glaucoma	7.02e-07	0.00069	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling by GPCR—C3—glaucoma	7.01e-07	0.000689	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NGFR—glaucoma	6.91e-07	0.000679	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN2B—glaucoma	6.7e-07	0.000659	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—SMO—glaucoma	6.68e-07	0.000657	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NTRK2—glaucoma	6.57e-07	0.000647	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NTRK1—glaucoma	6.56e-07	0.000646	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling by GPCR—C3—glaucoma	6.51e-07	0.00064	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CYP1B1—glaucoma	6.51e-07	0.00064	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—ABCA1—glaucoma	6.51e-07	0.00064	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NGFR—glaucoma	6.45e-07	0.000635	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—EDN1—glaucoma	6.43e-07	0.000632	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—GSTM1—glaucoma	6.41e-07	0.00063	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NGFR—glaucoma	6.35e-07	0.000625	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NTRK1—glaucoma	6.13e-07	0.000603	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NTRK2—glaucoma	6.11e-07	0.000601	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	6.05e-07	0.000595	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NTRK1—glaucoma	6.03e-07	0.000593	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NGF—glaucoma	5.91e-07	0.000581	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—EDN1—glaucoma	5.8e-07	0.000571	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—VEGFA—glaucoma	5.7e-07	0.000561	CbGpPWpGaD
Phentolamine—ADRA2B—Hemostasis—TP53—glaucoma	5.68e-07	0.000558	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—MTHFR—glaucoma	5.66e-07	0.000557	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	5.65e-07	0.000556	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NGFR—glaucoma	5.64e-07	0.000555	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—C3—glaucoma	5.61e-07	0.000552	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	5.56e-07	0.000547	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—EDN1—glaucoma	5.42e-07	0.000533	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NTRK1—glaucoma	5.36e-07	0.000527	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—EDN1—glaucoma	5.33e-07	0.000525	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NGF—glaucoma	5.33e-07	0.000525	CbGpPWpGaD
Phentolamine—ADRA2C—Hemostasis—TP53—glaucoma	5.3e-07	0.000522	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—APOE—glaucoma	5.27e-07	0.000519	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGFR—glaucoma	5.24e-07	0.000515	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—APOE—glaucoma	5.23e-07	0.000514	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—CAV1—glaucoma	5.22e-07	0.000514	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—GSTM1—glaucoma	5.2e-07	0.000512	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CAV1—glaucoma	5.18e-07	0.000509	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—C3—glaucoma	5.07e-07	0.000499	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NGF—glaucoma	4.98e-07	0.00049	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NTRK1—glaucoma	4.98e-07	0.00049	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	4.94e-07	0.000486	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—FN1—glaucoma	4.93e-07	0.000485	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NGF—glaucoma	4.9e-07	0.000482	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—BAD—glaucoma	4.87e-07	0.000479	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—EDN1—glaucoma	4.74e-07	0.000466	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—C3—glaucoma	4.73e-07	0.000466	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—APOE—glaucoma	4.72e-07	0.000464	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CAV1—glaucoma	4.68e-07	0.00046	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—C3—glaucoma	4.66e-07	0.000458	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—MTHFR—glaucoma	4.6e-07	0.000452	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	4.59e-07	0.000451	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—FN1—glaucoma	4.45e-07	0.000438	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—APOE—glaucoma	4.41e-07	0.000434	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—EDN1—glaucoma	4.4e-07	0.000433	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—BAD—glaucoma	4.4e-07	0.000433	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CAV1—glaucoma	4.37e-07	0.00043	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NGF—glaucoma	4.35e-07	0.000428	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—APOE—glaucoma	4.34e-07	0.000427	CbGpPWpGaD
Phentolamine—ADRA2A—Hemostasis—TP53—glaucoma	4.31e-07	0.000424	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CAV1—glaucoma	4.3e-07	0.000423	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—APOE—glaucoma	4.28e-07	0.000421	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—CAV1—glaucoma	4.24e-07	0.000417	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—FN1—glaucoma	4.16e-07	0.000409	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—C3—glaucoma	4.14e-07	0.000407	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—BAD—glaucoma	4.11e-07	0.000404	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—FN1—glaucoma	4.09e-07	0.000402	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NGF—glaucoma	4.05e-07	0.000398	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—BAD—glaucoma	4.04e-07	0.000398	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—NOS3—glaucoma	3.95e-07	0.000389	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—NOS3—glaucoma	3.92e-07	0.000385	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—APOE—glaucoma	3.85e-07	0.000379	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—C3—glaucoma	3.85e-07	0.000378	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CAV1—glaucoma	3.82e-07	0.000376	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—FN1—glaucoma	3.63e-07	0.000358	CbGpPWpGaD
Phentolamine—ADRA2C—Metabolism—PTGS2—glaucoma	3.61e-07	0.000355	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—BAD—glaucoma	3.59e-07	0.000353	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—APOE—glaucoma	3.58e-07	0.000352	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CAV1—glaucoma	3.55e-07	0.000349	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—NOS3—glaucoma	3.54e-07	0.000348	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	3.39e-07	0.000334	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—FN1—glaucoma	3.38e-07	0.000332	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—BAD—glaucoma	3.34e-07	0.000328	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—NOS3—glaucoma	3.3e-07	0.000325	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—NOS3—glaucoma	3.25e-07	0.00032	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—NOS3—glaucoma	3.21e-07	0.000316	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—MMP9—glaucoma	3.14e-07	0.000309	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	3.06e-07	0.000301	CbGpPWpGaD
Phentolamine—ADRA2A—Metabolism—PTGS2—glaucoma	2.93e-07	0.000289	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—NOS3—glaucoma	2.89e-07	0.000284	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	2.86e-07	0.000281	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—MMP9—glaucoma	2.84e-07	0.000279	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—VEGFA—glaucoma	2.82e-07	0.000278	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	2.82e-07	0.000277	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—NOS3—glaucoma	2.68e-07	0.000264	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—MMP9—glaucoma	2.65e-07	0.000261	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.61e-07	0.000257	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—VEGFA—glaucoma	2.55e-07	0.000251	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.5e-07	0.000246	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—VEGFA—glaucoma	2.38e-07	0.000234	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.34e-07	0.00023	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.32e-07	0.000229	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.32e-07	0.000228	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—MMP9—glaucoma	2.15e-07	0.000212	CbGpPWpGaD
Phentolamine—ADRA1D—Signaling Pathways—TP53—glaucoma	2.13e-07	0.00021	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—VEGFA—glaucoma	2.08e-07	0.000205	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.93e-07	0.00019	CbGpPWpGaD
Phentolamine—ADRA2B—Signaling Pathways—TP53—glaucoma	1.92e-07	0.000189	CbGpPWpGaD
Phentolamine—ADRA2C—Signaling Pathways—TP53—glaucoma	1.8e-07	0.000177	CbGpPWpGaD
Phentolamine—ADRA1B—Signaling Pathways—TP53—glaucoma	1.77e-07	0.000174	CbGpPWpGaD
Phentolamine—ADRA1A—Signaling Pathways—TP53—glaucoma	1.57e-07	0.000155	CbGpPWpGaD
Phentolamine—ADRA2A—Signaling Pathways—TP53—glaucoma	1.46e-07	0.000144	CbGpPWpGaD
